Navigation Links
Beckman Coulter Receives FDA Clearance of AccuTnI+3 Troponin I Assay on UniCel DxI Immunoassay Systems
Date:9/26/2013

BREA, Calif., Sept. 26, 2013 /PRNewswire/ -- Delivering the precision, clinical sensitivity and clinical specificity necessary to assist physicians with the diagnosis of myocardial infarction (MI), Beckman Coulter, Inc. announces the U.S. Food and Drug Administration (FDA) 510(k) clearance of its new Access AccuTnI+3 troponin I assay for use on the UniCel DxI series of immunoassay systems.

Following the June 2013 clearance of the Access AccuTnI+3 troponin I assay on Beckman Coulter's Access 2 immunoassay analyzer, the new troponin assay is now cleared for use on all of the company's immunoassay systems, as well as the UniCel DxC integrated chemistry and immunoassay series.

"The AccuTnI+3 troponin assay has been clinically proven through a large multi-center study that enrolled more than 1,900 subjects, and it is confirmed that the test provides the clinical performance needed for optimal patient management," said Arnd Kaldowski, president, Beckman Coulter Diagnostics. "Our new troponin I assay is directly aligned with the FDA's October 2010 guidance to manufacturers of troponin assays and confirms our commitment to modernize the performance evaluation of this critical test."

The new troponin I assay continues Beckman Coulter's long history of proven clinical performance in cardiac disease management and ensures that laboratories and clinicians can optimally assist physicians with the diagnosis of MI. AccuTnI+3 delivers clinical sensitivity and specificity aligned with contemporary use of troponin set forth by the FDA and utilizes platform-specific reagents and calibrators.

About Beckman Coulter
Beckman Coulter, Inc., based in Orange County, Calif., a subsidiary of Danaher Corporation (NYSE:

SOURCE Beckman Coulter, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Atonomics Achieves Significant Milestone Related to Performance Data for Troponin I Assay Triggering Scheduled Payments From Beckman Coulter
2. Apex BioStrategists Advises On Flow Cytometry Sale To Coulter
3. Lumena Pharmaceuticals Receives Orphan Drug Designation from US Food & Drug Administration for LUM001 in Four Rare Liver Diseases
4. MabVax Therapeutics Receives $1,750,000 Small Business Innovation Research Contract Award From The National Cancer Institute To Support Development of Novel Pancreatic Cancer Diagnostic Imaging Agent
5. B. Braun Receives FDA Approval For New Large-Volume Irrigation Containers
6. Chrysalis BioTherapeutics, Inc., Receives $1.5m from the National Cancer Institute to Mitigate Radiotherapy-Induced Brain Tissue Damage
7. B. Braun Receives FDA Approval For New Large-Volume Intravenous Containers
8. Orameds Platform Technology in Oral Delivery of Proteins Receives Patent in Russia
9. Boehringer Ingelheims investigational volasertib receives FDA Breakthrough Therapy designation
10. JenaValve TAVI System Receives Extended CE Mark Approval For Treatment Of Aortic Insufficiency
11. Berg Receives Frost & Sullivan 2013 Drug Discovery Technology Innovation Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 BreedIT Corp (OTC: ... worldwide distributor of highly sophisticated agro-breeding solutions for plant ... 2014, the Company,s board of directors appointed chemistry and ... its new member of the board. From ...
(Date:1/15/2014)... 2014  In an unprecedented effort to curb the spread of "superbugs" ... transport vehicles, an advanced and portable UV germicidal lamp manufactured by ... time. In order to prevent EMS paramedics and ... West Palm Beach Fire Rescue is the first ...
(Date:1/15/2014)... MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB ... composition of matter, biological targets, mechanism of action, methods ... This patent application describes a novel class ... which interfere with the basic homeostatic cellular processes in ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Superbugs No Longer Ride In Rescue Vehicles 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... announced that 12-month outcomes data from a subset analysis ... of print in the Journal of Interventional Cardiology ... company,s Genous Stent in diabetic patients, with low definite ... The study investigated the 1,236 diabetic patients from ...
... 23, 2011 NephRx Corporation today announced issuance ... peptide NX002, which currently is in preclinical development ... reported that NX002 had demonstrated significant efficacy when ...  Mucositis is a debilitating and often dose-limiting condition ...
Cached Medicine Technology:Data Published in the Journal of Interventional Cardiology Demonstrate Effectiveness and Safety of OrbusNeich's Genous™ Stent in Diabetic Patients 2Data Published in the Journal of Interventional Cardiology Demonstrate Effectiveness and Safety of OrbusNeich's Genous™ Stent in Diabetic Patients 3NephRx Corp. Awarded New U.S. Patent for Oral Mucositis Agent NX002 2NephRx Corp. Awarded New U.S. Patent for Oral Mucositis Agent NX002 3
(Date:4/23/2014)... Moffitt Cancer Center researchers say clinical trials for ... leukemia (AML) are very promising. Patients treated with ... and daunorubicin, are showing better responses than patients ... , "Acute myeloid leukemia is an aggressive ... success, especially in older patients," explained Jeffrey Lancet, ...
(Date:4/23/2014)... The American Society for Radiation Oncology (ASTRO) has ... Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based ... therapy in the treatment of endometrial cancer. The ... 2014 issue of Practical Radiation Oncology ... The full-length guideline is available as an open-access ...
(Date:4/23/2014)... novel compound that targets an important brain receptor has ... behaviors, including relapse behavior, a University at Buffalo animal ... that this may be a novel lead compound for ... The UB research was published as an online preview ... the study, the compound, RO5263397, severely blunted a broad ...
(Date:4/23/2014)... accessible detection methods that can rapidly screen a ... single cell inside that population has been seriously ... , In the Royal Society of Chemistry journal ... he and his coworkers have developed a novel ... protein ( Chem. Sci. , 2014, DOI: 10.1039/C4SC00578C, ...
(Date:4/23/2014)... Ill. - In a country as wealthy as the United ... 12 seniors do not have access to adequate food due ... food insecure. , Recent research at the University of ... Survey (NHANES) revealed that the seniors who are dealing with ... , "In 2011, 8.35 percent of Americans over age 60 ...
Breaking Medicine News(10 mins):Health News:Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2
... Florida have discovered a key gene that, when turned off, ... findings suggest that a combination of agents now being tested ... on, providing a much-needed therapy for the difficult-to-treat cancer. ... of kidney cancer, accounts for just 3 percent of all ...
... is available in French . Montreal, May 20, ... at the Montreal Heart Institute (MHI) by Dr. Jean-Claude Tardif are ... Tardif is a cardiologist and director of the MHI Research Centre, ... holder of the atherosclerosis research chair at the Universit de Montral. ...
... swarm. Even amoebae clump together in mystifyingly clever constellations. ... the cellular and molecular level to bring about this ... organisms into groups. It,s a choreography seen throughout nature ... as precise as the dance lineup of a Broadway ...
... ... Park Association (NRPA) is reminding Americans to take the proper steps to ensure that their ... The Dirty Dozen, a comprehensive brochure and playground-safety resource for playground managers, parents and caregivers. ... Ashburn, VA (Vocus) ...
... live inside every person that team plans to sequence ... effort to map out the genetic composition of hundreds ... first results: scientists report they have completed the genome ... , Found in such places as the gastrointestinal tract, ...
... ... 25 New York Verdicts of 2009. Applied Forensics is a 21st Century Forensics Laboratory ... ... Forensics LLP, a laboratory specializing in handwriting analysis, played an integral role in one ...
Cached Medicine News:Health News:Mayo Clinic researchers find gene they believe is key to kidney cancer 2Health News:Mayo Clinic researchers find gene they believe is key to kidney cancer 3Health News:Patients at high risk of recurrences of heart disease: Breakthrough in prevention 2Health News:Scientists discover the molecular heart of collective behavior 2Health News:Scientists discover the molecular heart of collective behavior 3Health News:Scientists discover the molecular heart of collective behavior 4Health News:Spring into Summer with The Dirty Dozen Guide to Playground Safety 2Health News:Spring into Summer with The Dirty Dozen Guide to Playground Safety 3Health News:Scientists Map Genetic Codes of Human Microbes 2Health News:Scientists Map Genetic Codes of Human Microbes 3Health News:Verdict Search recognizes Applied Forensics in Top 25 New York Verdicts of 2009 2
Image Diagnostics' Aspect100U is specifically designed for ease of use and high quality image outcome during urological procedures. Aspect tables benefit from a trim, lightweight design, ensuring a s...
The design of this table top is based on advanced functionality for specific urological requirements. This composite product sets a new standard for urological imaging....
... A revolutionary urological imaging ... benefits that translate into improved ... x 1k imaging technology physicians ... to see more anatomical detail ...
Drew Scientific has been making leading edge and top quality CBC systems for over 15 years.,The Excell 16/18 offers a reliable alternative for a 3 part differential....
Medicine Products: